[ad_1]
Industry experts say biotechs must prioritize validation, maturity, and alternative financing to overcome a lack of long-term funding.
[ad_2]
Funding lifelines: How to cross the 'valley of death'
Related Posts
Fireside Ventures Closes Fund IV at ₹2,265 Crore
[ad_1] You’re reading Entrepreneur India, an international franchise of Entrepreneur Media. Consumer-focused venture capital firm Fireside Ventures has closed its fourth fund at INR 2,265 […]
Temasek-backed AI venture firm Xora Innovation pppoints Eric Rosenblum as General Partner
[ad_1] Xora Innovation, an early-stage AI and deep tech venture firm backed by Singaporean state-owned investment firm Temasek, has appointed Eric Rosenblum as General Partner. […]
India launches credit support for e-commerce exporters under Export Promotion Mission
[ad_1] The initiative follows the announcement by the commerce ministry last month of credit facilities backed by interest subvention and partial credit guarantees to support […]